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ABSTRACT
Tellurium is a rare element which has been regarded as a toxic, non-essential trace element and its biological role is not
clearly established to date. Besides of that, the biological effects of elemental tellurium and some of its inorganic and
organic derivatives have been studied, leading to a set of interesting and promising applications. As an example, it can be
highlighted the uses of alkali-metal tellurites and tellurates in microbiology, the antioxidant effects of organotellurides
and diorganoditellurides and the immunomodulatory effects of the non-toxic inorganic tellurane, named AS-101,
and the plethora of its uses. Inasmuch, the nascent applications of organic telluranes (organotelluranes) as protease
inhibitors and its applications in disease models are the most recent contribution to the scenario of the biological effects
and applications of tellurium and its compounds discussed in this manuscript.
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INTRODUCTION
Tellurium is a rare element which has been regarded as
a non-essential, toxic element. Several literature reports
also stress that its compounds are highly toxic. Interest-
ingly, selenium was also considered a highly poisonous
element since the commencement of selenium related
science, until it got the status of being an absolute poison.
This pre-concept fell when selenium was identified as a
micronutrient for bacteria, mammals and birds (Schwarz
and Foltz 1957). Selenium was found in the active site
of mammalian gluthathione peroxidase as the unique 21st
amino acid, selenocysteine (Chambers et al. 1986, Hat-
field and Gladyshev 2002). The number of known sele-
noenzymes greatly grew as well as the mechanisms by
which those enzymes act. By now, tellurium biology and
biochemistry face the same prejudice of selenium, before
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the recognition of its biological role. The chemistry of
tellurium has a plethora of reactivity patterns but its bio-
chemistry is far less recognized than selenium. There-
fore, there are plenty of opportunities for the develop-
ment and establishment of tellurium participation in the
scenario of Biology and Medicine. Earlier, thorough re-
views concerning other aspects of tellurium compounds
were published, in relation to both their chemistry (Co-
masseto et al. 2007) and their pharmacological aspects
(Nogueira et al. 2004). This short review we present
herein has the aim to introduce a diversified view on the
biological effects of tellurium compounds.
GENERALITIES AND DEFINITIONS
Tellurium comes from the Latin “tellus”, meaning
“earth”, and was discovered by F.J. Mueller von Rei-
chenstein in 1782 from ores mined in the gold districts
of Transylvania (Bragnall 1966, Cooper 1971). Müller
called it metallum problematicum or aurum paradoxum
because it did not show any property of antimony, a
known impurity of gold. The discovery of tellurium
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occurred few years after the discovery of oxygen by J.
Priestley and C.W. Scheele, though the periodic group
relationship between the other chalcogens was not appar-
ent until nearly a century later. Tellurium is occasionally
found native, but is more often found as the telluride
of gold (calaverite) or combined with other metals. In
the environment, Te exists in its elemental (Te0), inor-
ganic -telluride ((Te2–), tellurite (TeO2−3 ), and tellurate(TeO2−4 )), and organic (dimethyl telluride (CH3TeCH3))forms (Cooper 1971). Of these, its oxyanion forms are
more common than its non-toxic, elemental state (Sum-
mers and Jacoby 1977). Presently, sparse research into
anthropogenic emissions of tellurium-based compounds
has been conducted and the implications of Te in the
air have yet to be investigated. Tellurium is a mem-
ber of the family of chalcogens. The German chemist
Wilhelm Blitz coined the term “chalcogen” (“ore for-
mers” from chalcos, old Greek for “ore”) for these el-
ements, and “chalcogenides” for their compounds (Fis-
cher 2001). Tellurium and selenium generate compounds
that are structurally related to their sulfur analogues,
but exhibit different properties and reactivities, being
thus considerably more toxic. As one descends the col-
umn, the chalcogens become larger and more polariz-
able than sulfur. Selenium has a lower electronegativity
and forms weaker bonds than sulfur (Whitham 1995).
The chemists found that selenium can be easily intro-
duced into molecules as a radical, a nucleophile, or an
electrophile. Tellurium has even greater metal like prop-
erties and is a true metalloid. In part, due to its po-
larizability, the C-Se bond is weaker than C-S bonds;
C-Te bonds are weaker yet, specially in the case of alkyl
derivatives which tend to decompose under heat and
light irradiation. This difference in bond energies may
explain why telluromethionine and tellurocysteine amino
acids have not been naturally found while selenocysteine
(the 21st amino acid) has been found in many organisms.
MAIN CLASSES OF TELLURIUM COMPOUNDS
Tellurium composes both inorganic and organic deriva-
tives. An inorganic tellurium compound differs from an
organic derivative because the former has at least one
tellurium-carbon bond in its structure. A number of dif-
ferent classes of organotellurium compounds are known.
The main classes are depicted in Chart 1. Those classes
can be divided in two distinct groups according to the
oxidation state of tellurium. The first group contains
the divalent derivatives. Tellurols are the analogues of
alcohols and thiols and are readily susceptible to oxi-
dation to ditellurides. Diorganotellurides are the ana-
logues of ethers and tioethers, have a formal oxidation
state of -2 and comprises the large set of studied organ-
otellurium compounds. Diorganoditellurides are related
to peroxides, being the products of oxidation of tellu-
rols. The second major group is composed by the hy-
pervalent derivatives in which tellurium has the oxida-
tion states of +4 and +6, and the classes of organotellu-
ranes composed by organotellurium trihalides, diorgano-
tellurium dihalides, organotellurium oxides, organotel-
lurates, and organopertelluranes (Chart 1).
BIOLOGICAL EFFECTS OF ELEMENTAL TELLURIUM
AND ITS INORGANIC DERIVATIVES
Tellurium found historical applications in the treatment
of microbial infections prior to the discovery of antibio-
tics. Early documentation in 1926 reports its use in the
treatment of syphilis and leprosy (De Meio and Hen-
riques 1947). Its oxyanion tellurite, TeO2−3 , has beenused in microbiology since the 1930s when Alexander
Fleming reported its antibacterial properties (Fleming
1932, Fleming and Young 1940). In 1984, it was sug-
gested that TeO2−3 could be a potential antisickling agentof red blood cells in the treatment of sickle cell ane-
mia (Asakura et al. 1984). In 1988, tellurium-containing
immunomodulating drugs were proposed as treatment
agents for AIDS; however, little has been done on it
since then (Jacobs 1989). This compound, AS-101, in-
hibits the production of IL-10, IFN-γ , IL-2R, and IL-
5 (Shohat et al. 2005), and also exhibits protection of
bone marrow stem cells during chemotherapy (Guest
and Uetrecht 2001). More recently, it has been found
other diverse activities of AS-101, such as the induction
of hair growth in both nude mice and in teenagers with
alopecia (Sredn et al. 2004); the inhibition of IL-1β
converting enzyme (caspase-1) (Brodsky et al. 2007);
protection against homocysteine-promoted apoptosis
(Okun et al. 2007a); the enhancement of neuronal sur-
vival in an ischemic stroke animal model (Okun et al.
2007b); and the protection and restoration of dopamin-
ergic neurons in a Parkinson’s disease model (Sredni et
al. 2007).
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Chart 1 – Classes of tellurium compounds mainly explored for the study of biological effects.
Tellurium biochemistry in the context of animal
and human toxicology was last reviewed by Taylor
(1996). Despite many chemical homologies between
selenium and tellurium, a nutritional role has never been
identified for tellurium. Moreover, tellurium, at low
concentrations, induces both acute and chronic toxicity
in a variety of organisms. Nevertheless, several studies
have shown that trace amounts of tellurium are present
in body fluids, such as blood and urine (Goulle’ et al.
2005). Tellurocysteine and telluromethionine can be
found in bacteria (Boles et al. 1995, Budisa et al. 1995,
1997), yeast (Yu et al. 1993), and fungi (Ramadan et
al. 1989) as a result of misincorporation of tellurium in
place of sulfur or selenium, thus allowing the expression
of protein analogs useful for protein structural studies
(Moroder 2005).
The toxicology of tellurium has been received less
attention than that of selenium. This may be a result of
the less frequent contact of man and animals with this
element and its compounds. Tellurium is less soluble
than selenium in physiological pH and the oxidation to
tellurite (TeO2−3 ), tellurate (TeO2−4 ) or TeO2 occurs eas-ily. Tellurium dioxide is practically insoluble in water at
physiological pH. The reduced form of tellurium, H2Te,more readily decomposes, by light or air, than H2Se; forthis reason, some authors attribute to tellurium a lower
potential toxicity than selenium (Sadeh 1987).
Both tellurium and/or its oxyanion forms act on
the enzyme squalene monooxygenase, the second en-
zyme in the committed pathway for cholesterol biosyn-
thesis. From the blockage of cholesterol synthesis, a
transient demyelination of peripheral nerves occur
(Wagner-Recio et al. 1991, Wagner et al. 1995). The
same effect has been observed with selenite and other
methylselenium compounds (Gupta and Porter 2002).
The sensitivity of squalene monooxygenase to tellurium
and selenium compounds is due to the binding of these
compounds to vicinal cysteines; the methylation of tel-
lurium in vivo may enhance the toxicity of tellurium for
this enzyme (Laden and Porter 2001). It has also been
observed that tellurite (TeO2−3 ) ions induce the alter-ation of the erythrocyte membrane and this activity is
thiol-dependent as well (Deuticke et al. 1992). Finally,
most of the Te(IV) derivatives are also able to inactivate
cysteine proteases, but not other families of proteases.
This seems to be related to the ability of Te(IV) com-
pounds to react with the thiolcatalytic site of cysteine
proteases. Te(VI) compounds do not exhibit any such
inhibitory activity as they are inert towards thiol moi-
eties (Albeck et al. 1998). Overall, the above work sug-
gests that tellurium compounds interact with biological
systems by specific chemical interaction with endoge-
nous thiols. More recently, another inorganic tellurium
compound, named SAS, was synthesized, and the in-
hibitory activity toward papain and cathepsin B described
as more potent than AS-101 as cysteine protease in-
hibitor (Yosef et al. 2007).
The precise biochemical explanation for the toxi-
city of oxyanions of the different chalcogens remains
largely unknown in bacteria. In general, it has been as-
sumed that the toxicity of tellurite is a consequence of
the strong oxidizing properties that lead to the forma-
tion of deleterious reactive oxygen species (Tremaroli et
al. 2007).
Tellurium and its inorganic compounds are biolog-
ically reactive and interact with organisms in a specific
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way. Some living organisms display can process non-
essential tellurium. As a form of defense, some bacteria
and fungi strains are able to metabolize tellurium salts in
their reductive metabolism, leading to biologically inert
Te0 or tellurolate (Te2–), which is methylated to volatile,
garlic smelling (H3C)2Te, in such a way that telluriumis eliminated from the medium where the microorgan-
ism is. The reduction and methylation of tellurium occur
also in mammals including humans. The injection of
tellurium salt solutions in animals lead to the formation
of Te0 and (H3C)2Te, which are eliminated by breath,urine and sweat (Chasteen and Bentley 2003).
Tellurate (TeO2−4 ) is about 2- to 10-fold less toxicthan tellurite in most organisms studied (Harrison et al.
2004). However, due to its poor solubility in aqueous
conditions, very little has been done with this form of
tellurium. Finally, as another effect of an inorganic form
of tellurium, it has been reported that tellurium tetra-
chloride is a reversible inhibitor of Zn2+ glicerolphos-
phocoline coline phosphodiesterase by tellurium tetra-
chloride (Sok and Kim 1992). This enzyme is found in
the nervous system and is related with the myelin basal
membrane homeostasis. It should be noted that tellu-
rium tetrachloride readly hydrolyses in water and, be-
cause of this, the tellurium specie responsible for the
inhibition was not clarified.
Aspects of the effects of selenium and tellurium
in microorganisms were recently covered in an exce-
lent review (Zannoni et al. 2008). An interesting ap-
plication of TeO2−3 consists in its use as an additive togrowth media for the selection and identification of var-
ious microorganisms, particularly those resistant to tel-
lurite, for almost 90 years. It is often employed in selec-
tive media to isolate a wide range of pathogens including:
Corynebacterium diphtheriae, Vibrio cholerae (Shimada
et al. 1990), Shigella spp. (Rahaman et al. 1986), and
verocytotoxigenic E. coli O157:H7 (the “hamburger dis-
ease” bacterium) (Zadic et al. 1993, Kormutakova et
al. 2000). Considerable work has been focused on the
pathogenic E. coli O157:H7 since this strain is highly
tolerant to metalloid anions. This allows the use of
tellurite-enriched media for its identification and isola-
tion. Tellurite is reduced in these strains, resulting in
a dark black colony. Tellurite is highlighted as a key
selection ingredient (De Boer and Heuvelink 2000) and
is also used in media to select Shiga toxin-producing
E. coli (STEC) O26 (Hiramatsu et al. 2002). How-
ever, a study on E. coli O46 and O15:H7 strains suggest
that there is no correlation between the tellurium resis-
tance and the ability to produce Shiga toxin (Taylor et
al. 2002). In addition to E. coli strains, tellurite has
been used in selection media for other organisms, includ-
ing Mycobacterium avium complex (Afghani and Fu-
jiyama 2001), methicillin-resistant Staphylococcus au-
reus (MSRA) (Zadic et al. 2001), pathogenic Vibrio spp.
(Donovan and van Netten 1995). Cefixime-tellurite me-
dia has been used for isolating organisms from minced
beef (Dogan et al. 2003), rectal swabs of cattle (Yilmaz
et al. 2002), raw vegetables (Fujisawa et al. 2002), and
sprouts (Fujisawa et al. 2000).
Tellurite and tellurate have also been proposed for
use in selective media for identification of fecal Strepto-
cocci (Saleh 1980). It is clear that tellurite has proven
to be a useful amendment for selection media in clinical
laboratory settings and will continue to do so. However,
this approach should be used with caution since non-
pathogenic strains can acquire tellurite resistance deter-
minants, thereby appearing in many clinical assays as
false positives.
A noteworthy possibility of exploring the microor-
ganism tellurium resistance is highlighted if one consid-
ers the unique challenges of the use of microorganisms
in environmental sciences. The exploitation of microor-
ganisms for the bioremediation of contaminated areas
is nowadays of particular interest. The use of antibio-
tic resistance markers in usual molecular biology tech-
niques may have deleterious consequences in the spread
of multi-drug resistance strains. It has been show that
the tellurium resistance genes can be used to follow
Pseudomonas putida following environmental release
for organic degradation (Sanchez-Romero et al. 1998).
Tellurite has also been used to detect and quantify the
release of Pseudomonas pseudoalcaligenes KF707 in
soils for polychlorinated biphenyl (PCB) degradation
(Zanaroli et al. 2002). Bacteria can mediate bioreme-
diation of tellurium either through direct sequestration,
bioreduction, or biomethylation. In sequestration, bac-
teria do not biotransform the chalcogen oxyanions into a
less toxic compound; the accumulation may occur either
through uptake or interaction with surface biomolecules
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Fig. 1 – Molecular structures of diorgano ditellurides used in toxicological studies.
acting in the form of an ion-exchange matrix. Bioreduc-
tion instead reduces the more toxic oxyanion forms to
the “non-toxic” Te0. This process usually occurs in-
tracellularly, leading to the precipitation of the metallic
form within the cell. Biomethylation leads to volatile
methyl derivatives that disperse into the atmosphere.
Thus, the chalcogen can travel considerable distances
providing detoxification of local contamination sites
through dilution by diffusion.
The tellurite resistance determinants kilAtelAB, ter,
tehAB, and arsABC were investigated for use in tellu-
rite remediation. The use of the plasmid borne tellurite
resistance determinant tehAB was found to facilitate the
largest amount of uptake of tellurite from the external
media (Turner et al. 1994). Highly resistant microbes
could also potentially be used for Te bioremediation.
Strains of marine purple non-sulfur bacteria with resis-
tance to 5mM tellurite were found to decrease the con-
centration of tellurite in the external media 100-fold and
led to accumulation of elemental tellurium deposits in
cells (Yamada et al. 1997). The bioreduction of toxic
inorganic forms of tellurium may have promising use for
aquifer contamination sites and the same techniques are
also applicable for other metalloid derivatives as well.
BIOLOGICAL EFFECTS
OF ORGANOTELLURIUM COMPOUNDS
There are just a few reports on the toxicology of organ-
otellurium compounds. Albeit the organotellurium com-
pounds were considered less toxic than the selenium
derivatives (Engman 1985), recent studies indicate the
contrary (Nogueira et al. 2004). It must be pointed that
research efforts are focused mainly on the effects of
diorganoditellurides. The systematic study on the bio-
logical effects of different classes of organotellurium
compounds is still an open branch of investigation.
Diphenylditelluride, (PhTeTePh) (1) have been ex-
tensively used in toxicological studies. The administra-
tion of doses of 1 to test animals showed an expressive
toxicity – LD50 < 1μmol/kg (rat); LD50 ≈ 150μmol/kg(mice). Mice survived for 72h after the administration
of doses of 500μmol/kg of 1 whereas 75% of rats
treated with doses of 0.75μmol/kg died. Inasmuch, the
administration to rats of shorter dosed of diphenylditel-
luride (0.5μmol/kg) showed an increase of alanine and
aspartate aminotransferase activities in serum indicative
of an induction of alteration in the normal function of
liver and kidney of the testing animals (Meotti et al.
2003).
The toxicology of organotellurium compounds have
been studied mainly by empirical methods based on the
relative toxicity observed in animals, or the evaluation of
effects in tissues or by the inhibition of cellular growth
(Sailer et al. 2004). For these reasons, Chasteen and
coworkers evaluated the toxicity of a series of diaryl
ditellurides (2-5, Fig. 1) to HL-60 cells by measuring
the induction of apoptosis by cell cytometry (Sailer et al.
2003). The ditellurides showed a meaningful apoptosis
induction in doses of 1μM, except for the ditelluride 4
which minimal dose was of 10μM.
Despite the toxic effects demonstrated for com-
pounds 1-5, applications of other classes of organic tel-
lurium compounds have been studied. Among them,
the most thoughtfully described effect is the antioxidant
properties of organic tellurides.
GSH acts as a reductor and as substrate of GSH per-
oxidases (GPx) and transferases. The GPx enzymes con-
tain selenium as selenocysteine at its active site and acts
in conjunction with GSH to avoid or minimize oxidative
damage in biomolecules. The biochemical function of
glutathione peroxidase is to reduce lipid hydroperoxides
to their corresponding alcohols and to reduce free hydro-
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gen peroxide to water. The GPx catalytic selenol (En-
zSeOH) is oxidized by hydroperoxides (ROOH) to sele-
nilic acid (EnzSeOH), leading also to the reduced form of
the hydroperoxide (ROH). The oxidized GPx (EnzSeOH)
reacts with GSH, leading to the mixed dichalcogenide
(EnzSeSG) which reacts with another GSH molecule,
forming oxidized gluthathione (GSSG) and restoring the
catalytic active GPx (Fig. 2).
Fig. 2 – Catalytic cycle of gluthathione peroxidases showing the
reduction of an organic hydroperoxide.
Since this process is related to the chemical re-
activity of the catalytic selenium, the exploitation of
organoselenides and organotellurides as GPx mimetics
are well covered in the literature. Due to the fundamen-
tal relevance of this process in aging and the potential
use of antioxidants as prospective drugs for oxidative
stress-related diseases, several studies have been under-
taken with selenium compounds that act as mimics of
GPx enzymes such as aromatic selenides and diseleni-
des, selenium heterocycles containing Se-N moiety, the
artificial selenosubtilysin, and selena-peptides among
other selenium derivatives (Mugesh et al. 2001). The
substitution of selenium for tellurium in arylic deriva-
tives greatly improves the antioxidant activity. Anders-
son and coworkers (1994) described the antioxidant ac-
tivity of organotellurium compounds in vitro. It was ob-
served the improvement on efficacy of tellurides 6 and
7 in the inhibition of lipid peroxidation of cells induced
by oxidative conditions (Fig. 3).
Fig. 3 – First organotellurium compounds used as antioxidants.
After this first report, the antioxidant activity of a
series of arylic tellurides 8a-k was compared with the
selenium heterocycle Ebselen, the first selenium com-
pound which the GPx-like activity was demonstrated in
chemical and biochemical systems (Fig. 4). The used
diaryltellurides were found to efficiently inhibit peroxi-
dation in rat hepatocytes, rat liver microssomes and an
organic solution of phosphatidylcholine (Andersson et
al. 1994).
Fig. 4 – Arylic tellurides used in the first demonstration of their
GPx-like activity.
The mechanism of the thiol-peroxidase activity of
organotellurides was studied further by Engman and co-
workers (1994). It was proposed that the organotellurox-
ide in the hydrate form reacts with thiols, producing
disulfides and regenerating the initial diorganotelluride
as shown in Figure 5.
Fig. 5 – Proposed mechanism of the GPx-like activity of diorganotel-
lurides (adapted from Engman et al. 1994).
From these initial studies, several groups have been
reporting the antioxidant activity of several organic tel-
lurides. A common observed feature consists in the great
antioxidant efficacy of tellurium derivatives in compar-
ison to sulfur or selenium analogues. It is notewor-
thy that diaryl tellurides inhibit lipid peroxidation much
longer than conventional antioxidants, indicating an au-
tocatalytic mechanism of antioxidant activity (Engman
et al. 1995). The antioxidant properties of organotel-
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lurium compounds were also demonstrated in complex
cellular systems, in which the abrogation of radical chain
reactions and the decomposition of peroxides were ob-
served (Wieslander et al. 1998). These make this class
of organotellurium compounds promising candidates for
the use in the developing antioxidant therapies. As an ex-
ample, the inhibition of thioredoxin/thioredoxin reduc-
tase system (TrxR) and cancer cell growth by antioxi-
dant organotellurium compounds structurally related to
vitamin E was reported (Engman et al. 2003). TrxR sys-
tem is a promising redox target for cancer therapy (Urig
and Becker 2006).
Another class of organotellurium compounds which
showed antioxidant activity is the diorgano ditellurides
(Fig. 6). Tellurium dichalcogenides are more efficient
antioxidants than selenium counterparts. Engman and
coworkers (1992) proposed a mechanism for the thiol-
peroxidase activity performing a series of elegant NMR
experiments. The ditellurides which presents in its
structure coordinating nitrogen groups exhibits a strong
secondary interaction between tellurium and nitrogen
atoms. Interestingly, it was observed an inverse linear
correlation among the force of the Te•••N secondary
interaction and the GPx-like activity: as the secondary
interaction gets stronger, the GPx-like activity dimin-
ishes.
Furthermore, more complex organotellurium com-
pounds with antioxidant activities were also described,
being the case of semisynthetic tellurosubtilisin (Mao et
al. 2005), dendrimeric organotellurides (Francavilla et
al. 2001, Ahsan et al. 2003); and tellurium-based poly-
meric surfactants. The thiol-peroxidase activity of these
systems was more active than the previously described
semi-synthetic tellurosubtilisin (Huang et al. 2006). In
a more sophisticated report, a nanoenzyme model with
glutathione peroxidase-like active site was built on poly-
styrene nanoparticle via microemulsion polymerization
(Huang et al. 2008). The nanoenzyme mimics showed
to be highly efficient, but the major achievement was the
demonstration that polymeric nanoparticles can be devel-
oped as excellent models for combining most of catalytic
factors of enzyme into one scaffold.
Organotellurium compounds also have found appli-
cations in Photodynamic therapy (PDT). PDT has been
developed as an alternative cancer therapy over the last
thirty-five years and had acquired regulatory approval in
several countries for carcinomas of the lung, digestive
tract, and genitourinary tract. PDT cancer treatment is
also in development for head, neck and pancreas carcino-
mas. The principle of this therapy is based in the use of
a sensitizer agent which is capable to interact with light
producing cytotoxic species or a cytotoxic reaction in
tumoral carcinoma, typically singlet oxygen (1O2) or su-peroxide from molecular oxygen (Leonard et al. 1999).
The sensitizer agent is generally porphirins, phthalocya-
nines or dyes, and may ideally present a preferential
interaction with tumoral cells. Detty and coworkers re-
ported the in vitro production of 1O2 by the irradiation ofan oxygen saturated solution of chalcogen-based dyes 14
shown in Figure 7 (Detty et al. 1990). In this first report,
a series of chalcogena-pyrilium salts were prepared and
characterized as inhibitors of cytochrome c oxidase in
tumoral cells. The damage induced by 9c was verified
by pronunciated morphological changes in mitochondria
from human glyoma cells. This report is noteworthy be-
cause it compares all possible chalcogen derivatives and
it was verified that the selenium and tellurium derivatives
were more efficient sensitizers.
More recently, Brennan and coworkers (2002) de-
veloped a novel class of chalcogena-pyrilium dyes (10),
more resistant to hydrolysis and structurally related to
the tio-pyrilium salt AA1, which has a defined and spe-
cific action on mitochondria (Fig. 8).
The antitumoral activity of the of the thiatellurocar-
bocyanine iodide 11 (Fig. 9) was found from a screen-
ing of 1000 lipophilic cationic compounds demonstrated
by Sun and coworkers (1996). Lipophilic cationic com-
pounds were found to be a class of antitumoral agents
due to its selective localization, accumulation and re-
tention within the mitochondria of certain tumoral cells
(Sun et al. 1996). Certain selectivity toward tumoral
cells was observed in vitro assays, in which 11 was 64-
fold more toxic to the CX-1 carcinoma cells in compari-
son to the epithelial CV-1 cell line. Regarding the in vivo
studies, the administration of 11 significantly prolonged
the survival of mice implanted with tumors. The action
of 11 on mitochondria was attributed by similarity of the
well-known effects of similar compounds like a thiopy-
rilium salt AA1 (Fig. 8), which is a potent inhibitor of
mitochondrial ATP hydrolysis (Davis et al. 1985).
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Fig. 6 – Diorganil ditellurides with mimetic GPx activity.
Fig. 7 – Molecular structure of chalcogena-pyrilium salts and the main strategy for its preparation.
Fig. 8 – Tellura-pyrilium salts related to AA1 and the synthetic approach to their access.
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Fig. 9 – Molecular structure of the thiatelluracarbocyanine iodide 11.
The effects of organotellurium(II) compounds were
described above. Another important group of organ-
otellurium compounds, the hypervalent organotellurium
compounds (organotelluranes), with described and nas-
cent applications, is described below. The biological
applications of organotelluranes are far less studied than
those of organotellurium(II) compounds.
The antihelminic of four organotelluranes (13-17)
was demonstrated against Trichinella spiralis infected
mice (Ordyntseva et al. 1988). The organotelluranes
13-15 were prepared by the reaction of the aryllithium
reagent 12 and TeI2 followed by the oxidation of the ob-tained organotellurides with chlorine or bromine. The
fourth organotellurane was prepared by the reaction of
the organotelluride 16 with phosphorous oxychloride,
followed by the sequence of reduction and oxidation with
bromine which lead to 17 (Scheme 1). The effect of these
compounds was compared with mebedazol; compound
15 did not show any activity, whereas 13 and 14 were less
effective than mebedazol; 17 showed similar activity.
Te
N
R
R' R'X X
1. TeI2
2. X2
N
R
R' R'
Li
Li
, R=R'=Me, X=Cl, R=R'=Me, X=Br, R=Et, R´=Br, X=Br
TeMe
NH Ph
O 1. POCl3, refluxo2. NaS2O3 Te
N
Br Br3. Br2
Scheme 1 – Synthesis of organotelluranes with anti-helmintic activity.
Soni and coworkers (2005) recently showed the
antibacterial activity of a series of unsymmetrical di-
organyltellurium dichlorides (18-22) (Fig. 10). It has
been found the antibacterial effect against gram-positive
(Baclilus subtilis, Staphylococcus aureus) and gram-neg-
ative bacteria (Escherichia coli, Pseudomonas aerugi-
nosa and Salmonella sp.). All tested compounds pre-
sented effect against gram-negative bacteria, and the 2-
naphtyl series (20-22) were most effective, but mecha-
nism of this effect was not demonstrated.
Fig. 10 – Organotelluranes with gram-negative antibacterial effect.
Inorganic and organic tellurium derivatives are
highly toxic for the central nervous system of rodents
(Maciel et al. 2000). Compounds 23, 24, and 25 (Fig. 11)
are potent inhibitors of either purified squalene mono-
oxigenase (Laden and Porter 2001) and also for its activ-
ity in cells (Goodrum 1998), causing a dramatic reduction
in cholesterol biosynthesis and leading to the degrada-
tion of myelin and further demyelinization of peripheral
nerves. The inactivation of squalene monooxigenase oc-
curs by the interaction of the telluranes and a pair of
vicinal thiols from the catalytic cysteine in the enzyme.
Dimethyltellurium dichloride 23 is the most potent in-
hibitor of this enzyme, and its effects on nerve cells are
very similar to those observed in the Te0-induced neu-
ropathy.
Fig. 11 – Tellurium-based inhibitors of cholesterol biosynthesis.
Finally, organotelluranes have been studied as pro-
tease inhibitors. The first description of this effect was
reported for inorganic telluranes (Albeck et al. 1998).
In this first seminal report, tellurium(IV), tellurium(VI)
compounds and the effect on the activity of the four
main classes of proteases were studied. It has been
found that just the inorganic tellurium(IV) compounds
exhibited a specific inhibitory activity towards cysteine
proteases papain and cathepsin B from bovine spleen.
More recently, an inorganic tellurane obtained from tar-
taric acid, named SAS, was also reported to be a more
potent inhibitor of papain and cathepsin B than AS-101
(Yosef et al. 2007) (Fig. 12). All of these compounds
(except TeO2) have been erroneously classified as organ-otellurium compounds, but since none of those possess
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any formal carbon-tellurium bond, it should be correctly
classified as inorganic tellurium compounds.
In comparison to those and other inorganic tellu-
ranes, the organotelluranes has a particular advantage.
Once the inorganic ones are limited to the availability
of the ligand, the organic ones can be obtained by the
oxidation of every organotellurium(II) compound which
can have a plethora of structural motifs. Taking this
into account, a small set of organotelluranes was eval-
uated as inhibitors of recombinant human cathepsin B
(Cunha et al. 2005). It was therefore observed that the
organotelluranes were potent inactivators of cathepsin B
(Fig. 13). The inactivation of cathepsin B was time- and
concentration- dependent and involves the modification
of enzyme´s catalytic thiol. The most interesting feature
of the organotellurane inhibition consists in the recov-
ery of the enzyme activity by the use of reducing agents
such as dithiothreitol (DTT). Docking studies have been
carried out using these and other organotellurium com-
pounds (Cunha et al. 2006). It is anticipated that the
information collected from this studies may be useful to
plan specific and more potent derivatives.
A larger collection of organotelluranes was further
assayed with recombinant cathepsins B, L, S and K to
seek for selectivity aspects on the inhibition of closely
related cysteine proteases (R.L.O.R. Cunha, I.E. Gouveia
et al., unpublished data). It was observed interesting in-
hibition profiles using these cathepsins which revealed
selective inactivation of each cathepsin with a differ-
ent organotelluranes, especially for cathepsins S and K.
Since the effect upon a biological target was established,
further exploration of the effects of organotelluranes, on
more complex models where the activity of cysteine pro-
teases is associated, has been explored. As examples,
it was described the effect of organotelluranes in an-
giogenesis and the cytotoxicity on several cancer cell
lineages (R.L.O.R. Cunha, T. Paschoalin et al., unpub-
lished data); the induction of apoptosis in human HL-60
cells (Abondanza et al. 2008). The protective effect of
an organotelluroxetane in an animal model of epilepsy
was also demonstrated. The pre-administration of the
organotelluranes avoided the establishment of the status
epilepticus in rats (Persike et al. 2008); as caspases were
described to be involved in epilepsy, the inactivation of
recombinant caspase-3 and caspase-8 was demonstrated
with the organotelluxetane, anionic organotelluranes and
AS-101. Once again, the organotelluranes were better in-
activators in comparison to AS-101. Finally, the effect
of organotelluranes in isolated mitochondria was inves-
tigated (Pessoto et al. 2007). It was found that these
compounds induce the formation of a transition pore in
mitochondria inner membrane (but avoids the oxidative
damage which usually arises); this was explained by the
formation of organotellurium(II) species from the inter-
action of the organotelluranes with membrane proteins.
CONCLUSIONS
Albeit the conventional prejudice concerning tellurium
and its compounds, the role of tellurium at the stage
of biology is at its beginning. Tellurium compounds
have a particular chemistry with thiol which is related
to many of the biological effects observed so far. Be-
sides of this, there are a lot of information and possible
new concepts waiting to be addressed to allow a ratio-
nal development of the uses of tellurium compounds in
biology and medicine. In particular, the fate of organ-
otellurium(II) in biological media, the reactivity of tel-
lurium compounds towards bionucleophiles and a broad
knowledge on other possible targets must be clarified
before further developments.
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RESUMO
O telúrio é um elemento não-essencial raro que vem sendo con-
siderado tóxico, e o seu papel biológico é ainda pouco esclare-
cido. Apesar disso, os efeitos biológicos do telúrio elementar
e de alguns derivados inorgânicos e orgânicos que têm sido
estudados revelam um conjunto de aplicações diversificadas
interessantes e promissoras. Como exemplo, pode-se destacar
os usos de teluritos e teluratos de metais alcalinos em micro-
biologia, o efeito antioxidante de teluretos e diteluretos orgâni-
cos, os efeitos imunomodulatórios e a diversidade de usos cor-
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Fig. 12 – Inorganic telluranes as specific cysteine protease inhibitors.
Fig. 13 – Organotelluranes with potent irreversible inactivation of recombinant human cathepsin B, above the molecular structures the second-
order inactivation rate constants determined for each compound is indicated.
relacionados a este efeito de uma telurana inorgânica denomi-
nada AS-101. Ademais, as aplicações de teluranas orgânicas
(organoteluranas) como inibidoras de proteases e as aplicações
em modelos de doenças compõem a mais recente contribuição
ao cenário dos efeitos e aplicações biológicas do telúrio e seus
compostos discutidas neste manuscrito.
Palavras-chave: antitumorais, aplicações biológicas, enzimas
inibidoras, compostos orgânicos de telúrio, proteases, telúrio.
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